Exploring the Gut Microbiota–Muscle Axis in Duchenne Muscular Dystrophy

Debora Mostosi,Monica Molinaro,Sabrina Saccone,Yvan Torrente,Chiara Villa,Andrea Farini

DOI: https://doi.org/10.3390/ijms25115589

IF: 5.6

2024-05-22

International Journal of Molecular Sciences

Abstract:The gut microbiota plays a pivotal role in maintaining the dynamic balance of intestinal epithelial and immune cells, crucial for overall organ homeostasis. Dysfunctions in these intricate relationships can lead to inflammation and contribute to the pathogenesis of various diseases. Recent findings uncovered the existence of a gut–muscle axis, revealing how alterations in the gut microbiota can disrupt regulatory mechanisms in muscular and adipose tissues, triggering immune-mediated inflammation. In the context of Duchenne muscular dystrophy (DMD), alterations in intestinal permeability stand as a potential origin of molecules that could trigger muscle degeneration via various pathways. Metabolites produced by gut bacteria, or fragments of bacteria themselves, may have the ability to migrate from the gut into the bloodstream and ultimately infiltrate distant muscle tissues, exacerbating localized pathologies. These insights highlight alternative pathological pathways in DMD beyond the musculoskeletal system, paving the way for nutraceutical supplementation as a potential adjuvant therapy. Understanding the complex interplay between the gut microbiota, immune system, and muscular health offers new perspectives for therapeutic interventions beyond conventional approaches to efficiently counteract the multifaceted nature of DMD.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

This paper attempts to explore the role of the bidirectional axis between the gut microbiota and muscles in Duchenne Muscular Dystrophy (DMD). Specifically, the paper focuses on the following points:

1. **Interaction between the gut microbiota and muscle axis**: The gut microbiota not only affects gut health but also influences the function and health of skeletal muscles through various pathways. Metabolites or bacterial fragments produced by the microbiota may migrate into the bloodstream and infiltrate distant muscle tissues, triggering inflammatory responses and exacerbating local pathology.

2. **Gut barrier dysfunction**: Dysbiosis of the gut microbiota may lead to damage to the intestinal epithelial barrier, thereby promoting bacterial translocation and secretion of inflammatory mediators, further leading to the occurrence and development of chronic inflammation. These changes can affect muscle function and may accelerate muscle atrophy.

3. **Role of metabolic products**: Microbial-derived compounds such as short-chain fatty acids (SCFAs), choline derivatives, polyamines, tryptophan, and its metabolites have immunomodulatory effects on muscles. For example, SCFAs have anti-inflammatory effects and can influence muscle metabolism and function through various mechanisms; tryptophan metabolites are associated with age-related frailty and muscle atrophy.

4. **Potential therapeutic strategies**: Given the important role of the gut microbiota in DMD, adjusting the gut microbiota through means such as fecal microbiota transplantation, prebiotics, and probiotics may become new adjunctive treatment methods. Existing studies have shown that restoring a normal gut microbiota can improve muscle function and reduce inflammatory responses.

In summary, this paper aims to reveal the complex relationship between the gut microbiota and DMD and to explore new therapeutic approaches based on microbiota regulation.